CervoMed Statistics
NASDAQ: CRVOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.28+0.10 (+3.14%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
After hours: 3.34 +1.73%
CervoMed by the numbers
CervoMed has a market capitalization of $49.6 million based on 15.12M shares outstanding. With trailing EPS of $-3.21, CervoMed is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 21.8% above its 50-day average and 17.6% below its 200-day average.
Average daily trading volume is 339.98K shares, or about $1.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CRVO valuation vs. peer median
| Metric | CRVO | Peer median | Difference |
|---|---|---|---|
| Market cap | $49.59M | $49.69M | -0% |
| Avg. volume | 339.98K | 259.61K | +31% |
Peer median across 8 companies: EDSA, ANVS, SER, HYPD, DWTX, ELTX, CELU, ACET.
Valuation
- Market cap
- $49.59M
- EPS (TTM)
- $-3.21
- Shares outstanding
- 15.12M
Price and trading
- Previous close
- 3.18
- Open
- 3.15
- Day range
- 3.13 – 3.31
- 52-week range
- 2.13 – 10.00
- 52-week change
- -62.72%
- Beta
- —
- Volume
- 329.37K
- Average volume
- 339.98K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 6, 2026
Additional statistics
- Market Cap
- 49.59M
- Forward Pe
- -2.22
- Eps
- -3.21
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 10.00
- Week52 Low
- 2.13
- Avg Volume
- 339.98K
- Shares Outstanding
- 15.12M
- Ma50
- 2.69
- Ma200
- 3.98
- Earnings Date
- Nov 6, 2026
- Pct From52w High
- -67.20%
- Pct From52w Low
- 53.99%